ABOUT
- Mission, Vision, Values
- Our Team
PARTNER WITH US
MEMBERS
RESOURCES
- Industry Insights
- News
CAREERS
CONTACT

Provider Roundtable on Present Findings of Medetomidine in Kentucky

Join Dr. Michael Frost, Chief Medical Officer at Wayspring, for an educational session on the emerging presence of medetomidine in Kentucky. Dr. Frost will review what medetomidine is, how it affects patients, key signs and symptoms of overdose and withdrawal, and lessons learned from trends observed in other parts of the country. This session will provide practical insights to help providers recognize, respond to, and prepare for the evolving challenges associated with this emerging substance.

Facilitator:

Michael Frost, MD, FACP, DFASAM

Chief Medical Officer, Wayspring

An internationally recognized expert in addiction medicine with deep experience in treatment, research, and healthcare policy.

Session Information:

12:00 PM ET

Monday, July 20, 2026

Held virtually via Microsoft Teams

Reserve Your Spot Below:

*No CME will be offered

JOIN THE CONVERSATION

Web Privacy Policy
Terms of Use
Member Privacy & Communication
Notice of Non-Discrimination
Compliance

All explicitly stated testimonials featured on this website are from real individuals sharing their personal experiences. Some imagery across this website depicts models for illustrative purposes only. For those who are not patients or providers, their participation does not constitute a testimonial or endorsement of any specific medical treatment or outcome.